Tag Archives: Anders Götzsche

H. Lundbeck A/S to acquire Prexton Therapeutics BV for EUR 100 million upfront and up to EUR 805 million in development and sales milestones paid later

Posted on 20, March 2018 by

Lundbeck will make an upfront payment of EUR 100 million and the deal terms also include up to EUR 805 million in development, regulatory and sales milestones Foliglurax is a first-in-class treatment which entered clinical phase II testing in Parkinson’s … Read the full press release →

Posted in Business, Denmark, Netherlands, Pharma & Biotech

Tagged , , , , , , , ,